The GoodHope Ehlers Danlos Syndrome Clinic: development and implementation of the first interdisciplinary program for multi-system issues in connective tissue disorders at the Toronto General Hospital.
Connective tissue disorders
Diagnosis and treatment
Ehlers Danlos Syndrome
Hypermobility spectrum disorders
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
10 08 2021
10 08 2021
Historique:
received:
03
09
2020
accepted:
18
07
2021
entrez:
11
8
2021
pubmed:
12
8
2021
medline:
7
10
2021
Statut:
epublish
Résumé
Ehlers-Danlos Syndrome (EDS) are a heterogeneous group of genetic connective tissue disorders, and typically manifests as weak joints that subluxate/dislocate, stretchy and/or fragile skin, organ/systems dysfunction, and significant widespread pain. Historically, this syndrome has been poorly understood and often overlooked. As a result, people living with EDS had difficulty obtaining an accurate diagnosis and appropriate treatment, leading to untold personal suffering as well as ineffective health care utilization. The GoodHope EDS clinic addresses systemic gaps in the diagnosis and treatment of EDS. This paper describes a leap forward-from lack of awareness, diagnosis, and treatment-to expert care that is tailored to meet the specific needs of patients with EDS. The GoodHope EDS clinic consists of experts from various medical specialties who work together to provide comprehensive care that addresses the multi-systemic nature of the syndrome. In addition, EDS-specific self-management programs have been developed that draw on exercise science, rehabilitation, and health psychology to improve physical and psychosocial wellbeing and overall quality of life. Embedded into the program are research initiatives to shed light on the clinical presentation, underlying mechanisms of pathophysiology, and syndrome management. We also lead regular educational activities for community health care providers to increase awareness and competence in the interprofessional management of EDS beyond our doors and throughout the province and country.
Identifiants
pubmed: 34376220
doi: 10.1186/s13023-021-01962-7
pii: 10.1186/s13023-021-01962-7
pmc: PMC8353438
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
357Informations de copyright
© 2021. The Author(s).
Références
Am J Med Genet A. 2019 Mar;179(3):356-364
pubmed: 30569502
Neurology. 2016 Jul 12;87(2):155-9
pubmed: 27306637
J Phys Ther Sci. 2018 Jun;30(6):843-847
pubmed: 29950777
BMC Musculoskelet Disord. 2015 Apr 15;16:89
pubmed: 25880527
N Engl J Med. 2000 Mar 9;342(10):673-80
pubmed: 10706896
Thorax. 1985 Apr;40(4):300-5
pubmed: 4023980
Int J Qual Stud Health Well-being. 2017 Dec;12(1):1371993
pubmed: 28866967
Am J Med Genet A. 2012 Aug;158A(8):2055-70
pubmed: 22786715
Sci Rep. 2017 Jan 04;7:39636
pubmed: 28051109
Arch Phys Med Rehabil. 2011 Jul;92(7):1106-12
pubmed: 21636074
Can J Cardiol. 2020 Mar;36(3):357-372
pubmed: 32145864
Auton Neurosci. 2018 Dec;215:89-96
pubmed: 29519641
Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):181-187
pubmed: 28186368
Pain. 2006 Sep;124(1-2):117-25
pubmed: 16698181
BMJ Open. 2019 Nov 4;9(11):e031365
pubmed: 31685485
Clin Rheumatol. 2015 Jun;34(6):1121-9
pubmed: 24487572
J Rheumatol. 1992 Jan;19(1):115-22
pubmed: 1556672
Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):237-245
pubmed: 28186381
Digit Health. 2020 Oct 13;6:2055207620962297
pubmed: 33117557
Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):226-236
pubmed: 28261938
JMIR Mhealth Uhealth. 2021 Mar 4;9(3):e26528
pubmed: 33661130
Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):195-211
pubmed: 28220607
Am J Med Genet C Semin Med Genet. 2017 Mar;175(1):8-26
pubmed: 28306229
Am J Med Genet A. 2020 Mar;182(3):484-492
pubmed: 31840928
Disabil Rehabil. 2017 Jul;39(14):1391-1397
pubmed: 27339264
Ann R Coll Surg Engl. 2015 Apr;97(3):e50-1
pubmed: 26263828